CEPI to fund development of broadly protective betacoronavirus vaccines in India
The CEPI has partnered with an autonomous research institute of the Indian government and a Delhi-based biotech firm to develop vaccines that provide broad protection against SARS-Cov-2 variants and other beta coronaviruses.
Richard Hatchett Translational Health Science Technology Institute Department Of Biotechnology Ministry Of Science Coalition For Epidemic Preparedness Innovations
Source: indiatoday.in